Expired Tender USA ICB TOT Ref. 117898757

Department of Defense Pharmacy Uniform Formulary Tender - 117898757

Tender notice from USA, published on 18 Apr 2025.

Executive Summary

The DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA) has issued a Tender notice for the procurement of a Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program in the USA. This Tender notice was published on 18 Apr 2025 and is scheduled to close on 24 Apr 2025, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 117898757, while the tender notice number is HT9402-25-Q-9203 and Register on the platform.

Key facts

Summary
Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
TOT Ref. No.
117898757
Document Ref. No.
HT9402-25-Q-9203
Country
USA
Notice type
Tender
Competition
ICB
Publication date
18 Apr 2025
Bid deadline
24 Apr 2025
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Description
The Department of Defense (DoD) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoD Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoD Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ.
P&T COMMITTEE MEETING: The following May 2025 newly approved drugs will be reviewed:
a. Alhemo - Antihemophilic Agents - Non-Factor Agentsb. Gomekli - Oncological Agents - N/Ac. Inzirqo - Diuretics - N/Ad. Otulfi - Targeted Immunomodulatory Biologics - Interleukin 23e. Pyzchiva - Targeted Immunomodulatory Biologics - Interleukin 23f. Raldesy - Antidepressants and Non-Opioid Pain Syndrome Agents - Serotonin Antagonist and Reuptake Inhibitorg. Romvimza - Oncological Agents - N/Ah. Ustekinumab-ttwe - Targeted Immunomodulatory Biologics - Interleukin 23i. Vykat XR - Metabolic Agents - Miscellaneous - N/Aj. Xromi - Oncological Agents - N/Ak. Zunveyl - Alzheimers Agents - N/A
The RFQ, including UF BPA and UF ADP appendices are attached here in. The instructions, i...
Active Contract Opportunity

Notice ID : HT9402-25-Q-9203

Related Notice

Department/Ind. Agency : DEPT OF DEFENSE

Sub-tier : DEFENSE HEALTH AGENCY (DHA)

Office: DEFENSE HEALTH AGENCY

General Information

Contract Opportunity Type: Solicitation (Updated)

Updated Published Date: Apr 17, 2025 12:05 pm CDT

Original Published Date: Mar 27, 2025 05:06 pm CDT

Updated Date Offers Due: Apr 24, 2025 12:00 pm CDT

Original Date Offers Due: Apr 17, 2025 12:00 pm CDT

Inactive Policy: Manual

Updated Inactive Date: Oct 24, 2025

Original Inactive Date: Oct 17, 2025

Initiative: None
Classification

Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS

NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance: San Antonio, TX 78230 USA

Documents

Tender Notice
Login to view
Amendment-0002.pdf
Login to view
A0002-RFQ-HT9402-25-Q-9203-NAD.pdf
Login to view
Price-List-Vykat-XR-Metabolic-Agents-Misc.xlsx
Login to view
Amendment-0001.pdf
Login to view
RFQ-HT9402-25-Q-9203-NAD.pdf
Login to view
Price-List-Alhemo-Antihemophilic-Agents-Non.xlsx
Login to view
Price-List-Gomekli-Oncological-Agents-NA.xlsx
Login to view
Price-List-Inzirqo-Diuretics-NA.xlsx
Login to view
Price-List-Otulfi-TIB-IL23.xlsx
Login to view
Price-List-Pyzchiva-TIB-IL23.xlsx
Login to view
Price-List-Raldesy-Antidepressants-non-opioid.xlsx
Login to view
Price-List-Romvimza-Oncological-Agents-NA.xlsx
Login to view
Price-List-Ustekinumab-ttwe-TIB-IL23.xlsx
Login to view
Price-List-Xromi-Oncological-Agents-NA.xlsx
Login to view
Price-List-Zunveyl-Alzheimers-Agents-NA.xlsx
Login to view
Price-Appendix-FAQ-NAD.pdf
Login to view
DoD-Formulary-Placement-of-FDA-Newly-Approved-Drug.pdf
Login to view

USA Public Procurement Intelligence

Frequently asked questions

The bid deadline for Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program was 24 Apr 2025. Bidding is closed.

This tender has been issued by DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA) in USA.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 117898757. The purchaser document reference is HT9402-25-Q-9203.

Browse other tenders from USA or search by relevant keywords and CPV classification.